Mwanzo1099 • HKG
add
Sinopharm Group Co Ltd
Bei iliyotangulia
$ 18.30
Bei za siku
$ 18.22 - $ 18.42
Bei za mwaka
$ 16.02 - $ 23.65
Thamani ya kampuni katika soko
57.42B HKD
Wastani wa hisa zilizouzwa
8.44M
Uwiano wa bei na mapato
7.56
Mgao wa faida
3.97%
Ubadilishanaji wa msingi
HKG
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 141.66B | -3.81% |
Matumizi ya uendeshaji wa biashara | 6.72B | -6.59% |
Mapato halisi | 1.46B | 2.59% |
Kiwango cha faida halisi | 1.03 | 7.29% |
Mapato kwa kila hisa | — | — |
EBITDA | 3.70B | -5.19% |
Asilimia ya kodi ya mapato | 23.38% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 45.36B | -32.44% |
Jumla ya mali | 415.08B | — |
Jumla ya dhima | 285.93B | — |
Jumla ya hisa | 129.16B | — |
hisa zilizosalia | 3.12B | — |
Uwiano wa bei na thamani | 0.71 | — |
Faida inayotokana na mali | 1.96% | — |
Faida inayotokana mtaji | 3.85% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.46B | 2.59% |
Pesa kutokana na shughuli | -34.28B | 27.81% |
Pesa kutokana na uwekezaji | 617.49M | 141.09% |
Pesa kutokana na ufadhili | 12.88B | -41.88% |
Mabadiliko halisi ya pesa taslimu | -20.78B | 17.10% |
Mtiririko huru wa pesa | -14.13B | — |
Kuhusu
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Ilianzishwa
2003
Tovuti
Wafanyakazi
108,217
